Arvinas
IPO News: File S-1: Arvinas Files $100mm IPO
Arvinas

Arvinas

NASDAQ: ARVN

Initial Filing Date:  08/30/18

Size:  $100mm

Bookrunners: Goldman Sachs | Citi | Piper Jaffray  

Major Holders:  Canaan IX LP | 5AM Partners | Craig Crews Family Trust (Founder) | RA Capital Management | OrbiMed Capital | Nextech V Oncology | Named Executives

Description: Arvinas is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins.

Note: Emerging Growth Company

Reference Link:  S-1